“They said it would be easy so just do it already.”
— Michael Lin, Stanford University associate professor of neurobiology and bioengineering, in a Twitter post urging drug companies to update their COVID-19 vaccines for the now-dominant omicron variant. Pfizer and Moderna have since begun trials for an omicron-specific vaccine.